Suven Life Sciences secures product patent from, S Korea, Macau, Israel
DSIJ Intelligence / 10 Jul 2017
Suven Life Sciences Ltd informed on Monday that it has secured one product patent from South Korea, one from Israel and one from Macau.
Suven Life Sciences Ltd informed on Monday that it has secured one product patent from South Korea, one from Israel and one from Macau.
The product patents correspond to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases and these patents are valid through CY 2032.
The granted claims of the patents are from the mechanism of action include the class of selective H3 inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like alzheimer’s disease, attention deficient hyperactivity disorder (ADHD), huntington’s disease, major depressive disorder (MDD), Parkinson and schizophrenia.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.